DarioHealth Corp. - 10-Q Filing
DarioHealth Corp. filed its Q1 2026 10-Q with financial results showing a net loss of $4.5 million, or $0.63 per share, compared to a net loss of $3.8 million in the same period last year. Revenue increased by 17% YoY to $1.9 million due to higher sales through its B2B2C channel and direct-to-consumer growth.
Tickers: $DRIO